Merck has signed a new equipment supply agreement with the Swiss contract development and manufacturing organisation (CDMO) Celonic.
The client is upgrading its manufacturing facility in Basel with five of Merck's Mobius single-use bioreactors, with 50, 200 and 2,000-litre bioreactors to augment its development and manufacturing capabilities.
“Merck is providing five of its Mobius single-use bioreactors to the contract development and manufacturing organisation Celonic.“
It is expected that this upgrade will expand Celonic's upstream capabilities, offering greater batch success rates, less cross-contamination risk, decreased water requirements, shortened project duration and reduced project costs compared to conventional stainless steel systems.
Andrew Bulpin, head of Merck's process solutions business unit, said: "Our extensive portfolio of single-use technologies allows us to support CDMO customers like Celonic as they adopt new technologies and expand their capabilities."
The firm is supplying bioreactor technology to a wide range of manufacturers, several of which are already collaborating with the company in this space in North America, Europe and Asia.
This reflects growing demand for end-to-end solutions that help to cut manufacturing costs while increasing quality and efficiency.
With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Science